Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Asia: A report from the Global Opioid Policy Initiative (GOPI)

Annals of Oncology

Volumn 24, Issue SUPPLEMENT11, 2013, Pages

  Cleary, J ^a,b   Radbruch, L ^c,d   Torode, J ^e   Cherny, N I ^f,g  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN   (United States)

^c UNIVERSITY HOSPITAL BONN   (Germany)

^d Malteser Hospital Bonn/Rhein Sieg Bonn   (Germany)

^e Union for International Cancer Control   (Switzerland)

^f SHAARE ZEDEK MEDICAL CENTER   (Israel)

^g ESMO Palliative Care Working Group   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; FENTANYL; METHADONE; MORPHINE; NARCOTIC ANALGESIC AGENT; OXYCODONE;

AFGHANISTAN; ARTICLE; ASIA; BANGLADESH; CAMBODIA; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CHINA; DRUG COST; DRUG FORMULARY; DRUG FORMULATION; DRUG RELEASE; EDUCATION; EMERGENCY MEDICINE; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE POLICY; HONG KONG; HUMAN; INDIA; INDONESIA; JAPAN; KAZAKHSTAN; LAOS; MALAYSIA; MEDICAL SOCIETY; MONGOLIA; MYANMAR; NEPAL; PAKISTAN; PHILIPPINES; PRESCRIPTION; PRIORITY JOURNAL; SOUTH KOREA; SRI LANKA; THAILAND; VIET NAM;

ANALGESICS, OPIOID; ASIA; HEALTH POLICY; HEALTH SERVICES ACCESSIBILITY; HUMANS; LICENSURE; MORPHINE; NEOPLASMS; PAIN; PAIN MANAGEMENT; PALLIATIVE CARE; PHYSICIAN'S PRACTICE PATTERNS;

EID: 84889067551     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt500     Document Type: Article

References (20)

1. Lynch T, Connor S, Clark D. Mapping levels of palliative care development: a global update. J Pain Symptom Manage 2013; 45(6): 1094-1106.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127(12): 2893-2917.
3. The Quality of Death: Ranking end-of-life care across the world [Internet]. eiu.com. (cited 2013 Oct 12). http://www.eiu.com/site_info.asp?Info_name= qualityofdeath_lienfoundation&page=noads.
4. Cleary J, Simha N, Panieri A et al. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in India: a report from the Global Opioid Policy Initiative (GOPI). Ann Oncol 2013; 24(Suppl 11): xi33-xi40.
5. Cherny NI, Cleary J, Scholten W et al. The Global Opioid Policy Initiative (GOPI) project to evaluate the availability and accessibility of opioids for the management of cancer pain in Africa, Asia, Latin America and the Caribbean, and the Middle East: introduction and methodology. Ann Oncol 2013; 24(Suppl 11): xi7-xi13.
6. Cleary J, Silbermann M, Scholten W et al. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in the Middle East: a report from the Global Opioid Policy Initiative (GOPI). Ann Oncol 2013; 24(Suppl 11): xi51-xi59.
7. Duthey B, Scholten W. Adequacy of opioid analgesic consumption at country, global, and regional levels in 2010, its relationship with development level, and changes compared with 2006. J Pain Symptom Manage 2013. http://eutils.ncbi. nlm.nih.gov/entrez/eutils/elink.fcgi?Dbfrom=pubmed&id=23870413&retmode= ref&cmd=prlinks (in press).
8. Seya M-J, Gelders SFAM, Achara OU et al. A first comparison between the consumption of and the need for opioid analgesics at country, regional, and global levels. J Pain Palliat Care Pharmacother 2011; 25(1): 6-18.
9. International Narcotics Control Board. Report of the International Narcotics Control Board on the availability of internationally controlled drugs: ensuring adequate access for medical and scientific purposes New York: United Nations. 2011; 1-88.
10. World Health Organization. Ensuring balance in national policies on controlled substances: Guidance for availability and accessibility of controlled medicines Geneva: World Health Organization; 2011; pp88. http://www.who.int/medicines/areas/quality_safety/guide_nocp_sanend/en/index.html.
11. De Lima L, Krakauer EL, Lorenz K et al. Ensuring palliative medicine availability: the development of the IAHPC list of essential medicines for palliative care. J Pain Symptom Manage 2007; 33(5): 521-526.
12. Mauer M, Bishnu P, Dowla R et al. Asian Pacific Hospice Congress 2013 Proceedings. The International Pain Policy Fellowship. Bangkok. Oct 2013.
13. Eguchi K. Development of palliative medicine for cancer patients in Japan: from isolated voluntary effort to integrated multidisciplinary network. Jpn J Clin Oncol 2010; 40(9): 870-875.
14. Yamaguchi T, Shima Y, Morita T et al. Clinical guideline for pharmacological management of cancer pain: The Japanese Society of Palliative Medicine Recommendations. Jpn J Clin Oncol 2013; 43(9): 896-909.
15. Srisawany P, Harun-Or-Rashid, Horosaw T et al. Knowledge, attitudes and barriers of physicians, policy makers/regulators regarding use of opioids for cancer pain management in Thailand. Nagoya J Med Sci 2013; 75: 201-212.
16. Javier FO, Calimag MP. Opioid use in the Philippines-20 years after the introduction of the WHO analgesic ladder. European J Pain 2012; 1(S1): 19-22.
17. Morita TT, Miyashita MM, Shibagaki MM et al. Knowledge and beliefs about endof-life care and the effects of specialized palliative care: a population-based survey in Japan. J Pain Symptom Manage 2006; 31(4): 11-11.
18. Bosnjak S, Maurer MA, Ryan KM et al. Improving the availability and accessibility of opioids for the treatment of pain: the International Pain Policy Fellowship. Support Care Cancer 2011; 19(8): 1239-1247.
19. Krakauer EL, Ngoc NTM, Green K et al. Vietnam: integrating palliative care into HIV/AIDS and cancer care. J Pain Symptom Manage 2007; 33(5): 578-583.
20. Cleary J, Radbruch L, Torode J et al. Next steps in access and availability of opioids for the treatment of cancer pain: reaching the tipping point? Ann Oncol 2013; 24(Suppl 11): xi60-xi64.